Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency
Clinical trial NCT02693522 · COMPLETED
Trial details
- NCT number
- NCT02693522
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2004-12-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.